These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15926870)

  • 1. The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity.
    Small CJ; Bloom SR
    Expert Opin Investig Drugs; 2005 May; 14(5):647-53. PubMed ID: 15926870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut hormones and the control of appetite.
    Small CJ; Bloom SR
    Trends Endocrinol Metab; 2004 Aug; 15(6):259-63. PubMed ID: 15358278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of food intake in obese subjects by peptide YY3-36.
    Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
    N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide YY: a potential therapy for obesity.
    Renshaw D; Batterham RL
    Curr Drug Targets; 2005 Mar; 6(2):171-9. PubMed ID: 15777187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal hormones and regulation of food intake.
    Dhillo WS; Bloom SR
    Horm Metab Res; 2004; 36(11-12):846-51. PubMed ID: 15655718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
    Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
    Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.
    Wynne K; Bloom SR
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):612-20. PubMed ID: 17082808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat.
    Abbott CR; Small CJ; Sajedi A; Smith KL; Parkinson JR; Broadhead LL; Ghatei MA; Bloom SR
    Int J Obes (Lond); 2006 Feb; 30(2):288-92. PubMed ID: 16231018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut hormones and appetite control.
    Wren AM; Bloom SR
    Gastroenterology; 2007 May; 132(6):2116-30. PubMed ID: 17498507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of peptide YY in integrative gut physiology and potential role in obesity.
    Grudell AB; Camilleri M
    Curr Opin Endocrinol Diabetes Obes; 2007 Feb; 14(1):52-7. PubMed ID: 17940420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of peptide YY in appetite regulation and obesity.
    Karra E; Chandarana K; Batterham RL
    J Physiol; 2009 Jan; 587(1):19-25. PubMed ID: 19064614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in circadian and meal-induced gut peptide levels in lean and obese rats.
    Moghadam AA; Moran TH; Dailey MJ
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1786-1794. PubMed ID: 29191090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.
    Vazquez Roque MI; Camilleri M; Stephens DA; Jensen MD; Burton DD; Baxter KL; Zinsmeister AR
    Gastroenterology; 2006 Dec; 131(6):1717-24. PubMed ID: 17087952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide YY, appetite and food intake.
    le Roux CW; Bloom SR
    Proc Nutr Soc; 2005 May; 64(2):213-6. PubMed ID: 15960866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.
    Field BC; Wren AM; Peters V; Baynes KC; Martin NM; Patterson M; Alsaraf S; Amber V; Wynne K; Ghatei MA; Bloom SR
    Diabetes; 2010 Jul; 59(7):1635-9. PubMed ID: 20357366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.